PB Bankshares 株価情報 (NASDAQ: PBBK)

最新ニュース PB Bankshares (NASDAQ:PBBK) 株価情報

PB Bankshares

PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.

PB Bankshares Inc

Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) reported quarterly earnings of $2.82 per share which beat the analyst consensus estimate of $2.72 by 3.68 percent. This is a 8.88 percent increase over earnings of $2.59 per share from the same period last year. The company reported quarterly sales of $2.21 billion which beat the analyst consensus estimate of $2.20 billion by 0.18 percent. This is a 0.96 percent increase over sales of $2.18 billion the same period last year.

Earnings

Earnings Beats

News

Global Payments Q1 Adj. EPS $2.82 Beats $2.72 Estimate, Sales $2.21B Beat $2.20B Estimate

Treehouse Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.19) by 84.21 percent. This is unchanged from the same period last year. The company reported quarterly sales of $796.00 million which beat the analyst consensus estimate of $790.42 million by 0.71 percent. This is a 3.01 percent decrease over sales of $820.70 million the same period last year.

Treehouse Foods Q1 Adj. EPS $(0.03) Beats $(0.19) Estimate, Adj. Sales $796.00M Beat $790.42M Estimate

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains Corcept Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) with a Buy and lowers the price target from $150 to $145.

Price Target

Analyst Ratings

CORT

HC Wainwright & Co. Maintains Buy on Corcept Therapeutics, Lowers Price Target to $145

Energizer Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>) is looking for Q3 GAAP EPS of $0.36-$0.53..

Guidance

Energizer Hldgs Sees Q3 GAAP EPS $0.36-$0.53

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Church &amp; Dwight Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHD#NYSE">CHD</a>)</h3>
<ul>
<li>On May 1, Church &amp; Dwight reported worse-than-expected first-quarter sales results, issued second-quarter adjusted EPS guidance below estimates, and cut its FY25 adjusted EPS guidance. Rick Dierker, Chief Executive Officer, commented, &#8220;In an environment of slowing consumption, our brands are performing well. We continue to drive both dollar and volume share gains across most of our brands. Our balanced portfolio of value and premium products keep us well positioned to navigate this environment.&#8221; The company's stock fell around 10% over the past month and has a 52-week low of $91.76.</li>
<li>RSI Value: 27.2</li>
<li>CHD Price Action: Shares of Church &amp; Dwight fell 0.2% to close at $92.78 on Monday.</li>
<li>Edge Stock Ratings: 34.50 Momentum score with Value at 20.09. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/CHD"><img loading="lazy" decoding="async" width="497" height="176" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06044316/image-45.png" alt="" class="wp-image-902769" style="width:359px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06044316/image-45.png 497w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06044316/image-45-300x106.png 300w" sizes="(max-width: 497px) 100vw, 497px" /></a></figure>
<h3 class="wp-block-heading">Tyson Foods Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On May 5, Tyson Foods reported worse-than-expected second-quarter sales results. Tyson Foods reported quarterly earnings of 92 cents per share which beat the analyst consensus estimate of 82 cents per share. The company reported quarterly sales of $13.07 billion which missed the analyst consensus estimate of $13.14 billion. The company's stock fell around 7% over the past five days and <a href="https://www.benzinga.com/quote/TSN">has a 52-week low</a> of $53.61.</li>
<li>RSI Value: 23.4</li>
<li>TSN Price Action: Shares of Tyson Foods dipped 7.8% to close at $56.08 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0506">TSN stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0506"><img loading="lazy" decoding="async" width="913" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06044417/image-46.png" alt="" class="wp-image-902773" style="width:584px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06044417/image-46.png 913w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06044417/image-46-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06044417/image-46-768x707.png 768w" sizes="(max-width: 913px) 100vw, 913px" /></a></figure>
<h3 class="wp-block-heading">BRC Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>)</h3>
<ul>
<li>On May 5, BRC posted a wider-than-expected quarterly loss. &#8220;Black Rifle is off to a promising start in 2025, driven by distribution gains across multiple product categories and targeted investments that position us well for sustained, multi-year growth,&#8221; said BRCC Chief Executive Officer Chris Mondzelewski. The company's stock fell around 26% over the past six months and has a 52-week <a href="https://www.benzinga.com/quote/BRCC">low of $1.89.</a></li>
<li>RSI Value: 28.7</li>
<li>BRCC Price Action: Shares of BRC gained 3.5% to close at $2.37 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0506">BRCC shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0506"><img loading="lazy" decoding="async" width="885" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06044504/image-47.png" alt="" class="wp-image-902774" style="width:466px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06044504/image-47.png 885w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06044504/image-47-300x282.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06044504/image-47-768x722.png 768w" sizes="(max-width: 885px) 100vw, 885px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/markets/25/05/45192607/jim-cramer-applied-materials-is-an-excellent-company-but-likes-this-tech-stock-more">Jim Cramer Says Applied Materials Is An &#8216;Excellent&#8217; Company, But Likes This Tech Stock More</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

BRCC

Top 3 Risk Off Stocks You'll Regret Missing This Month

WIIM

PONY

Pony.ai shares are trading higher after the company announced a partnership with Uber to deploy its robotaxis on the Uber platform.

Energizer Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>) lowers FY2025 Adj EPS guidance from $3.45-$3.65 to $3.30-$3.50 vs $3.55 analyst estimate. Widens FY2025 sales outlook from $2.92 billion-$2.94 billion to $2.89 billion-$2.94 billion vs $2.93 billion estimate.

Energizer Hldgs Lowers FY2025 Adj EPS Guidance from $3.45-$3.65 to $3.30-$3.50 vs $3.55 Est; Widens FY2025 Sales Guidance from $2.92B-$2.94B to $2.89B-$2.94B vs $2.93B Est

Energizer Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>) lowers FY2025 GAAP EPS guidance from $2.63-$2.95 to $2.29-$2.65..

Energizer Hldgs Lowers FY2025 GAAP EPS Guidance from $2.63-$2.95 to $2.29-$2.65

Telsey Advisory Group analyst Sarang Vora maintains BRC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>) with a Outperform and maintains $4 price target.

Telsey Advisory Group Maintains Outperform on BRC, Maintains $4 Price Target

TDUP

ThredUp shares are trading higher after the company reported better-than-expected Q1 results and raised its FY25 sales guidance.

Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRP#NYSE">NRP</a>) reported quarterly earnings of $2.97 per share. This is a 22.45 percent decrease over earnings of $3.83 per share from the same period last year. The company reported $60.54 million in sales this quarter. This is a 20.78 percent decrease over sales of $76.41 million the same period last year.

Natural Resources Q1 EPS $2.97 Down From $3.83 YoY, Total revenues and other income $60.54M Down From $76.41M YoY

PINC

Premier shares are trading higher after the company reported better-than-expected Q3 results and raised its FY25 adjusted EPS guidance.

Kontoor Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KTB#NYSE">KTB</a>) is looking for Q2 Adj EPS of $0.80 vs $1.11 analyst estimate. sees sales of $630.000 million vs $629.42 million analyst estimate.

Kontoor Brands Sees Q2 Adj EPS $0.80 vs $1.11 Est; Sees Sales $630.000M vs $629.42M Est

Kontoor Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KTB#NYSE">KTB</a>) raises FY2025 Adj EPS guidance from $5.20-$5.30 to $5.40-$5.50 vs $4.95 analyst estimate. Raises FY2025 sales outlook from $2.63 billion-$2.69 billion to $3.06 billion-$3.09 billion vs $2.65 billion estimate.

Kontoor Brands Raises FY2025 Adj EPS Guidance from $5.20-$5.30 to $5.40-$5.50 vs $4.95 Est; Raises FY2025 Sales Guidance from $2.63B-$2.69B to $3.06B-$3.09B vs $2.65B Est

BRLT

Brilliant Earth Sees Q2 Sales Growth Of -3% to 0% Year-Over-Year And Adjusted EBITDA Of -$1.5M To +$2M; Reiterates 2025 Outlook

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) with a Buy and lowers the price target from $9 to $4.

EKSO

HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Lowers Price Target to $4

Telsey Advisory Group analyst Cristina Fernandez maintains Ethan Allen Interiors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETD#NYSE">ETD</a>) with a Market Perform and lowers the price target from $32 to $30.

Telsey Advisory Group Maintains Market Perform on Ethan Allen Interiors, Lowers Price Target to $30

Kontoor Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KTB#NYSE">KTB</a>) reported quarterly earnings of $1.20 per share which beat the analyst consensus estimate of $1.16 by 3.45 percent. This is a 3.45 percent increase over earnings of $1.16 per share from the same period last year. The company reported quarterly sales of $622.90 million which missed the analyst consensus estimate of $626.32 million by 0.55 percent. This is a 1.32 percent decrease over sales of $631.20 million the same period last year.

Earnings Misses

Kontoor Brands Q1 Adj. EPS $1.20 Beats $1.16 Estimate, Sales $622.90M Miss $626.32M Estimate

Gartner FY2025  expected to be more than $11.70 vs $12.15 Est; FY2025  Revenue expected to be more than $6.54B vs $6.55B Est

Energizer Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>) reported quarterly earnings of $0.67 per share which met the analyst consensus estimate. This is a 6.94 percent decrease over earnings of $0.72 per share from the same period last year. The company reported quarterly sales of $662.90 million which missed the analyst consensus estimate of $669.58 million by 1.00 percent. This is a 0.06 percent decrease over sales of $663.30 million the same period last year.

Comments

PB Bankshares

ニュース

最新ニュース PB Bankshares (NASDAQ:PBBK) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル